Cortical Layer Markers

Learn about the development of cortical layers, and explore the specific markers for each layer to use in your IHC, ICC-IF, or Western blot assays.

Download article

Cortical layer markers are useful tools for studying the cerebral cortex's development, functional neuroanatomy, and pathology. The cerebral cortex is organized into six layers of both morphologically and functionally divergent neurons. The different layers can be identified using antibodies against protein markers expressed in specific layers.

Development and characteristics of cortical layers

Cortical layers are formed during embryonal development.

The neuronal layers in the cortex generate in a strictly regulated manner during embryonal development. Specifically, layers V and VI, the deeper layers, develop after the formation of the cortical plate. Layers II-IV, the upper layers neurons, are formed after the deeper layers. Glial cells, including astrocytes and oligodendrocytes, generate at the latest stages of cortical development.

Tissue expression of selected transcriptional factors involved in the development of cerebral cortex. Immunohistochemical staining with Anti-LHX2 antibody (AMAb91404) shows strong immunoreactivity in the developing cortex and sensory organs of mouse embryo E11 (A). PAX6 expression is detected in both developing brain and sensory organs (B), including eye (C) (Anti-PAX6 antibody AMAb91372). MEF2C is primarily expressed in the upper layers of the developing cortex, as shown by Anti-MEF2C antibody (AMAb90728) in mouse embryo E14 (D).

Neocortical neurogenesis is dependent on several transcriptional factors. For instance, LHX2 and PAX6 together play a crucial role in the specification of neocortical progenitors, giving rise to the projection neurons. MEF2C is another example of a transcription factor essential for normal neural development and spatial distribution in the neocortex.

Anatomical and functional diversity in neurons of different layers

Neurons of different layers are anatomically and functionally diverse in the mature neocortex. Neuronal cell morphology, physiological properties, and anatomical connections vary between the layers. Neurons of layers II/III, along with a subset of neurons of layer V, contribute primarily to intracortical connections, including callosal projections to the contralateral cerebral hemisphere. Layer V corticofugal neurons target the midbrain, hindbrain, and spinal cord, while layer VI neurons project mainly to the thalamus.

Laminar distribution of protein expression profiles in the cerebral cortex of rat. RELN immunoreactivity is mainly detected in the neuropil of layer I (Anti-RELN antibody AMAb91365) (A, F). CUX1 expression is seen in layers II-IV (Anti-CUX1 antibody HPA003277) (B, G). BCL11B (CTIP2) is expressed primarily in layers V and VI (Anti-BCL11B antibody HPA049117) (C, H). Layer VI neurons show strong expression of FOXP2 (Anti-FOXP2 antibody AMAb91362) (D, I). Layer VIb can be identified by presence of CTGF immunoreactivity (Anti-CTGF antibody AMAb91366) (E, J).

The cortical layer markers CUX1, POUF3F2, BCL11B, and FOXP2

Protein expression profiles differ in neurons of various layers. For instance, upper layers neurons can be identified by expression of CUX1 and POU3F2 (BRN2), the neurons of layer V by expression of BCL11B (CTIP2), and layer VI can be identified by FOXP2 expression.

Laminar structure of cerebral cortex of rat shown by multiplexed immunofluorescence with the Anti-CUX1 antibody (HPA003277, in blue), the Anti-NECAB1 antibody (AMAb90800, in green) and the Anti-FOXP2 antibody (AMAb91362, in red). Note that CUX1 is mainly expressed in layers II-III, NECAB1 shows strongest expression in layer IV neurons, while FOXP2 is primarily present in layer VI neurons.

Antibodies targeting cortical layer I

Layer 1: Anti-RELN monoclonal antibody (AMAb91365)

Validated for ICC-IF
Verified species reactivity: human

Cortical Layer Markers

Development and characteristics of cortical layers

Cortical layers are formed during embryonal development.

Anatomical and functional diversity in neurons of different layers

The cortical layer markers CUX1, POUF3F2, BCL11B, and FOXP2

Antibodies targeting cortical layer I

Layer 1: Anti-RELN monoclonal antibody (AMAb91365)

Layer 1: Anti-RELN polyclonal antibody (HPA046512)

Antibodies targeting upper cortical layers

Layer 2/3: Anti-RASGRF2 polyclonal antibody (HPA018679)

Layer 2/3: Anti-CALB1 polyclonal antibody (HPA023099)

Layer 2/3-4: Anti-CUX1 monoclonal antibody (AMAb91352)

Layer 2/3-4: Anti-CUX1 monoclonal antibody (AMAb91353)

Layer 2/3-4: Anti-CUX1 polyclonal antibody (HPA003277)

Layer 2/3, 4 and 5b: Anti-POU3F2 (BRN2) polyclonal antibody (HPA056261)

Layer 2/3, 4 and 5b: Anti-POU3F2 (BRN2) monoclonal antibody (AMAb91406)

Layer 2/3, 4 and 5b: Anti-POU3F2 (BRN2) monoclonal antibody (AMAb91407)

Layer 2-4 (mainly 4): Anti-NECAB1 monoclonal antibody (AMAb90798)

Layer 2-4 (mainly 4): Anti-NECAB1 monoclonal antibody (AMAb90800)

Layer 2-4 (mainly 4): Anti-NECAB1 monoclonal antibody (AMAb90801)

Layer 2-4 (mainly 4): Anti-NECAB1 polyclonal antibody (HPA023629)

Layer 2-4 (mainly 4): Anti-NECAB1 polyclonal antibody (HPA031262)

Antibodies targeting deeper cortical layers V and VI

Layer 5: Anti-PCP4 polyclonal antibody (HPA005792)

Layer 5: Anti-CNTC6 polyclonal antibody (HPA016645)

Layer 5-6: Anti-BCL11B (CTIP2) polyclonal antibody (HPA049117)

Layer 6: Anti-FOXP2 monoclonal antibody (AMAb91361)

Layer 6: Anti-FOXP2 monoclonal antibody (AMAb91362)

Layer 6: Anti-FOXP2 polyclonal antibody (HPA000382)

Layer 6: Anti-TLE4 polyclonal antibody (HPA065357)

Layer 6b: Anti-CTGF monoclonal antibody (AMAb91366)

Layer 6b: Anti-CTGF polyclonal antibody (HPA031075)